HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Blumer, I. R. Search for Related Content PubMed PubMed Citation Articles by Blumer, I. R. Social Bookmarking                What's this?

Severe Injection Site Reaction to Insulin Detemir

From the Charles H. Best Diabetes Centre, Ajax, Ontario, Canada

Address correspondence to Dr. Ian R. Blumer, 401-95 Bayly St. West, Ajax, ON, Canada. E-mail: ian@ianblumer.com

The first 20% of the full text of this article appears below.

Insulin detemir is a new long-acting insulin analog. Though generally well tolerated, injection site reactions have been reported in 2% of insulin detemir users (1). Most commonly, these untoward reactions manifest as mild injection site erythema or discomfort and seldom lead to discontinuation of the product. Herein, I report the case of a patient with a severe local reaction to insulin detemir necessitating its withdrawl.

A 37-year-old Caucasian woman with a 25-year history of type 1 diabetes was switched from . . . [Full Text of this Article]

CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				S. VAN HATTEM, A. H. BOOTSMA, and H. B. THIO Skin manifestations of diabetes Cleveland Clinic Journal of Medicine, November 1, 2008; 75(11): 772 - 787. [Abstract] [Full Text] [PDF]

				S. E. Fineberg, T. T. Kawabata, D. Finco-Kent, R. J. Fountaine, G. L. Finch, and A. S. Krasner Immunological Responses to Exogenous Insulin Endocr. Rev., October 1, 2007; 28(6): 625 - 652. [Abstract] [Full Text] [PDF]

				L. Stechemesser, M. Hofmann, T. Hawranek, and R. Weitgasser Type III Allergy to Insulin Detemir: Response to Darmon et al. Diabetes Care, December 1, 2006; 29(12): 2758 - 2758. [Full Text] [PDF]